1-Year Outcomes of PT-Valve for Pulmonary Regurgitation in Native Outflow Tract
The PT-Valve demonstrated a high success rate of implantation and favorable safety and efficacy in the treatment of PR through 1 year. This device is anatomically suitable for more than 90% of PR patients with native RVOT. (Prospective, Single Arm, Multi-Center Clinical Study on the Safety And Efficacy of the Sterile Transcatheter Pulmonary Valve and Delivery System; ChiCTR2100043367).
Authors
- ChangDong Zhang
- Cheng Xue Qin (ORCID: https://orcid.org/0000-0003-2169-2686)
- Nianguo Dong (ORCID: https://orcid.org/0000-0001-5437-599X)
- Xiaoke Shang (ORCID: https://orcid.org/0000-0002-3263-5428)
- Mei Liu (ORCID: https://orcid.org/0000-0003-2114-7143)
Institutions
- Union Hospital (HK)
- Wuhan Union Hospital (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- JACC Asia
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1016/j.jacasi.2024.12.014
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78